Natera, INC Form 4 insider transactions

Jonathan Sheena, a Director of Natera, Inc., sold 6,000 shares of common stock on August 10, 2026 for $325.32 per share.

Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 2,000 shares of common stock on August 7, 2026 for $320.90 per share.

Jonathan Sheena, a Director of Natera, Inc., sold 9,150 shares of common stock on August 7, 2026.

Michael Burkes Brophy, CHIEF FINANCIAL OFFICER of Natera, Inc., sold 795 shares of common stock on August 3, 2026.

Steven Leonard Chapman, CEO AND PRESIDENT and a Director of Natera, Inc., sold 3,076 shares of common stock on August 3, 2026.

John Fesko, PRESIDENT, CHIEF BUS. OFFICER of Natera, Inc., sold 295 shares of common stock on August 3, 2026 for $267.99 per share.

Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., sold 3,410 shares of common stock on August 3, 2026.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., sold 334 shares of common stock on August 3, 2026 for $267.99 per share.

Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 731 shares of common stock on August 3, 2026 for $267.99 per share.

Jonathan Sheena, a Director of Natera, Inc., sold 109 shares of common stock on August 3, 2026 for $267.99 per share.

Jonathan Sheena, a Director of Natera, Inc., sold 479 shares of common stock on July 27, 2026.

Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 1,718 shares of common stock on July 27, 2026 for $260.49 per share.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., sold 1,887 shares of common stock on July 27, 2026.

Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., sold 2,214 shares of common stock on July 27, 2026.

John Fesko, PRESIDENT, CHIEF BUS. OFFICER of Natera, Inc., sold 1,713 shares of common stock on July 27, 2026.

Steven Leonard Chapman, CEO AND PRESIDENT and a Director of Natera, Inc., sold 5,770 shares of common stock on July 27, 2026.

Michael Burkes Brophy, CHIEF FINANCIAL OFFICER of Natera, Inc., sold 5,064 shares of common stock on July 27, 2026.

Jonathan Sheena, a Director of Natera, Inc., sold 1,500 shares of common stock on July 15, 2026.

Rowan E Chapman, a Director of Natera, Inc., sold 135 shares of common stock on July 15, 2026 for $274.82 per share.

Jonathan Sheena, a Director of Natera, Inc., sold 3,150 shares of common stock on July 13, 2026.

Natera, Inc. Executive Chairman Matthew Rabinowitz has sold 1,000 shares of common stock, valued at approximately $280 per share, as part of a pre-arranged Rule 10b5-1 trading plan.

Natera, Inc. reports that its SEC and Chief Legal Officer, Daniel Rabinowitz, sold a total of 17,994 shares of common stock on July 1, 2026, through a pre-arranged Rule 10b5-1 trading plan.

Natera Inc. reports insider Solomon Moshkevich sold 2,900 shares of common stock on July 1, 2026, as part of a pre-arranged trading plan.

Natera, Inc. reports that Director Eric H. Rubin was issued 75 Restricted Stock Units (RSUs) as compensation for his board services.

Natera, Inc. reports a Form 4 filing detailing transactions by Director Herm Rosenman, including the acquisition of restricted stock units and the disposal of common stock.

Natera, Inc. director Marcus Gail Boxer was issued restricted stock units (RSUs) and vested RSUs on June 26, 2026, as part of his compensation and service to the company.

Natera, Inc. reports that Director Thomas J. Lynch Jr. was granted Restricted Stock Units (RSUs) valued at $425,000, with vesting over three years.

Natera, Inc. reports that Director Rowan Chapman acquired restricted stock units (RSUs) and common stock on June 26, 2026.

Natera, Inc. director Roelof Botha has reported transactions involving restricted stock units (RSUs), including an issuance for services and a grant that vests in 2027.

Natera, Inc. reports that Director Monica Bertagnolli acquired restricted stock units (RSUs) as compensation for board services and in lieu of retainer fees.